Cosmeceuticals for Cellulite

Seminars in Cutaneous Medicine and Surgery

Volumn 30, Issue 3, 2011, Pages 167-170

  Hexsel, Doris ^a,b   Soirefmann, Mariana ^a,b  

^a Brazilian Center for Studies in Dermatology   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cellulite; Cosmeceuticals; Free radicals; Lipogenesis; Lipolysis; Microcirculation flow; Physiopathology; Topical treatments

Indexed keywords

COSMETIC;

ADIPOSE TISSUE; DERMIS; LIPOGENESIS; LIPOLYSIS; MICROCIRCULATION; REVIEW; SKIN SURFACE; SUBCUTANEOUS TISSUE;

ADIPOSE TISSUE; COSMETICS; FEMALE; HUMANS; MICROCIRCULATION; OBESITY; PHYTOTHERAPY; PLANT PREPARATIONS; SUBCUTANEOUS TISSUE;

EID: 80052975074     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.1016/j.sder.2011.06.005     Document Type: Review

References (29)

1. Hexsel D., Zechemeister do Prado D., Goldman M.P. Topical management of cellulite. Cellulite: Pathophysiology and Treatment 2010, 62-68. Informa Health Care, London, England. M. Goldman, D. Hexsel (Eds.).
2. Draelos Z.D., Marenus K.D. Cellulite. Etiology and purported treatment. Dermatol Surg 1997, 23:1177-1181.
3. Harvard Women's Health Watch Cellulite meltdown. Harv Health Pub Group 1998, 5:7.
4. Querleux B., Cornillon C., Jolivet O., et al. Anatomy and physiology of subcutaneous adipose tissue by in vivo magnetic resonance imaging and spectroscopy: Relationships with sex and presence of cellulite. Skin Res Technol 2002, 8:118-124.
5. Piérard G.E., Nizet J.L., Piérard-Franchimont C. Cellulite: From standing fat herniation to hypodermal stretch marks. Am J Dermatopathol 2000, 22:34-47.
6. Hexsel D.M., Abreu M., Rodrigues T.C., et al. Side-by-side comparison of areas with and without cellulite depressions using magnetic resonance imaging. Dermatol Surg 2009, 35:1471-1477.
7. Khan M.H., Victor F., Rao B., et al. Treatment of cellulite: Part I. Pathophisiology. Am Acad Dermatol 2010, 62:361-370.
8. Rossi A.B.R., Vergnanini A.L. Cellulite: a review. J Eur Acad Dermatol Venerol 2000, 14:251-262.
9. Cellulite G.M.P. A review of current treatments. Cosmet Dermatol 2002, 15:17-20.
10. Martin K.L., Ailor S.K. An ounce of prevention. Mo Med 2011, 108:64-68.
11. Manela-Azulay M., Bagatin E. Cosmeceuticals vitamins. Clin Dermatol 2009, 27:469-474.
12. Khan M.H., Victor F., Rao B., et al. Treatment of cellulite: part II. Advances and controversies. J Am Acad Dermatol 2010, 62:373-384. quiz 385-6.
13. Botanicals A.F.S. A Phytocosmetic Desk Reference 1999, CRC Press, Boca Raton, FL.
14. Hexsel D., Orlandi C., Zechmeister do Prado D., et al. Botanical extracts used in the treatment of cellulite. Dermatol Surg 2005, 31:866-873.
15. Rubanyi G., Marcelon G., Vanhoutte P.M. Effect of temperature on the responsiveness of cutaneous veins to the extract of Ruscus aculeatus. Gen Pharmacol 1984, 15:431-434.
16. Berg D. Venous constriction by local administration of ruscus extract [in German]. Fortschr Med 1990, 108:473-476.
17. Carle R. Anti-inflammatory and spasmolytic botanical drugs. Breast J Phytother 1990, 1:32-39.
18. Pineapple, in The Lawrence Review of Natural Products-Monograph System. Facts and Comparisons 2001, Wolters Kluwer, St. Louis, MO.
19. Facino R.M., Carini M., Stefani R., et al. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: Factors contributing to their efficacy in the treatment of venous insufficiency. Arch Pharm (Weinheim) 1995, 328:720-724.
20. Sainio E.L., Rantanen T., Kanerva L., et al. Ingredients and safety of cellulite creams. Eur J Dermatol 2000, 10:596-603.
21. Lesser T., Ritvo E., Moy L.S., et al. Modification of subcutaneous adipose tissue by a methylxanthine formulation: A double-blind controlled study. Dermatol Surg 1999, 25:445-462.
22. Draelos Z.D., Marenus K.D. Cellulite. Etiology and purported treatment. Dermatol Surg 1997, 23:1177-1181.
23. Bertin C., Zunino H., Pittet J.C., et al. A double-blind evaluation of the activity of an anti-cellulite product containing retinol, caffeine, and ruscogenine by a combination of several non-invasive methods. J Cosmet Sci 2001, 52:199-210.
24. Dias M., Farinha A., Faustino E., et al. Topical delivery of caffeine from some commercial formulations. Int J Pharm 1999, 182:41-47.
25. Potard G., Laugel C., Baillet A., et al. Quantitative HPLC analysis of sunscreens and caffeine during in vitro percutaneous penetration studies. Int J Pharm 1999, 189:249-260.
26. Velasco M.V., Tano C.T., Machado-Santelli G.M., et al. Effects of caffeine and siloxanetriol alginate caffeine, as anticellulite agents, on fatty tissue: Histological evaluation. J Cosmet Dermatol 2008, 7:23-29.
27. Collis N., Elliot L.A., Sharpe C., et al. Cellulite treatment: A myth or reality: A prospective randomized, controlled trial of two therapies, endermologie and aminophylline cream. Plast Reconstr Surg 1999, 104:1110-1114.
28. Kligman A.M., Pagnoni A., Stoudmayer T. Topical retinol improves cellulite. J Dermatol Treat 1999, 10:119-125.
29. Machinal-Quélin F., Dieudonné M.N., Leneveu M.C., et al. Expression studies of key adipogenic transcriptional factors reveal that the anti-adipogenic properties of retinol in primary cultured human preadipocytes are due to retinol per se. Int J Cosmet Sci 2001, 23:299-308.